ArticleJournal of neuro-oncology2017

Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.

C Kurokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.